Literature DB >> 8608373

Adjunct therapies to surgical management of keloids.

B Berman1, H C Bieley.   

Abstract

BACKGROUND: The literature describing surgical treatments, with or without supplementary nonsurgical treatments for keloids, offers a confusing picture of widely variable "success" rates, recurrence rates, patient populations, and follow-up periods.
OBJECTIVE: A review of the surgical treatment of keloids with emphasis on surgery combined with nonsurgical therapies is presented.
RESULTS: Surgery alone leads to recurrence rates ranging from 45 to 100%. When surgery is combined with intradermal corticosteroids the recurrence rate in the majority of studies falls below 50%. Surgery combined with button compression therapy on earlobes led to no recurrences. External radiation following excision, often combined with other therapies, has been associated with recurrence rates of less than 10%. Various lasers have been used in the treatment of keloids with great variability in the recurrence rate but in general result in similar recurrence rates as conventional surgery. As with cryodestruction, laser ablation recurrence rates often are improved when combined with other treatments. Inferon-alpha 2b injected after keloid excision demonstrated, in a small series of patients an 8% recurrence rate.
CONCLUSION: Presently, it appears that a combined therapeutic approach offers the most propitious possibility for preventing keloid recurrence.

Entities:  

Mesh:

Year:  1996        PMID: 8608373     DOI: 10.1111/j.1524-4725.1996.tb00493.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  30 in total

Review 1.  [The treatment of keloids].

Authors:  I Hackert; R Aschoff; G Sebastian
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

2.  Keloid explant culture: a model for keloid fibroblasts isolation and cultivation based on the biological differences of its specific regions.

Authors:  Vanina Monique Tucci-Viegas; Bernardo Hochman; Jerônimo P França; Lydia M Ferreira
Journal:  Int Wound J       Date:  2010-10       Impact factor: 3.315

3.  Use of organotypic coculture to study keloid biology.

Authors:  Paris D Butler; Daphne P Ly; Michael T Longaker; George P Yang
Journal:  Am J Surg       Date:  2008-02       Impact factor: 2.565

4.  Consensus Guidelines on the Use of Superficial Radiation Therapy for Treating Nonmelanoma Skin Cancers and Keloids.

Authors:  Mark S Nestor; Brian Berman; David Goldberg; Armand B Cognetta; Michael Gold; William Roth; Clay J Cockerell; Brad Glick
Journal:  J Clin Aesthet Dermatol       Date:  2019-02-01

5.  [Hyperplastic scars and keloids. Part I: basics and prevention].

Authors:  A Baisch; F Riedel
Journal:  HNO       Date:  2006-11       Impact factor: 1.284

6.  Radiation Therapy Following Total Keloidectomy: A Retrospective Study over 11 Years.

Authors:  Kyuhee Kim; Daegu Son; Jinhee Kim
Journal:  Arch Plast Surg       Date:  2015-09-15

7.  A Multicenter Randomized Controlled Trial Evaluating a Cx43-Mimetic Peptide in Cutaneous Scarring.

Authors:  Christina L Grek; Jade Montgomery; Meenakshi Sharma; A Ravi; J S Rajkumar; Kurtis E Moyer; Robert G Gourdie; Gautam S Ghatnekar
Journal:  J Invest Dermatol       Date:  2016-11-14       Impact factor: 8.551

8.  Role of Hyaluronic Acid Treatment in the Prevention of Keloid Scarring.

Authors:  Andrea Hoffmann; Jessica Lynn Hoing; Mackenzie Newman; Richard Simman
Journal:  J Am Coll Clin Wound Spec       Date:  2013-07-01

9.  Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens.

Authors:  Gisele V Oliveira; Hal K Hawkins; David Chinkes; Ann Burke; Andre Luiz Pasqua Tavares; Marcia Ramos-e-Silva; Thomas B Albrecht; Gregory T Kitten; David N Herndon
Journal:  Int Wound J       Date:  2009-12       Impact factor: 3.315

10.  Cutaneous scarring: a clinical review.

Authors:  Richard Baker; Fulvio Urso-Baiarda; Claire Linge; Adriaan Grobbelaar
Journal:  Dermatol Res Pract       Date:  2010-02-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.